Maria Rachele Bianchi

Clinical spectrum and IgG subclass analysis of anti-myelin oligodendrocyte glycoprotein antibody-associated syndromes: a multicenter study

Sara Mariotto, Sérgio Ferrari, Salvatore Monaco et al. · Journal of Neurology · 2017 · 166 citations · Full text

Life Sciences, Neurology, Neuroscience +15

<i>Response to Therapy in Myasthenia Gravis with Anti‐MuSK Antibodies</i>

Amelia Evoli, Maria Rachele Bianchi, Raffaella Riso et al. · Annals of the New York Academy of Sciences · 2008 · 157 citations

Life Sciences, Immunology, Pharmacotherapy +16

Prognostic value of multimodal evoked potentials in multiple sclerosis: the EP score

Paolo Invernizzi, Laura Bertolasi, Maria Rachele Bianchi et al. · Journal of Neurology · 2011 · 64 citations

Life Sciences, Neurology, Neuroscience +13

Are Natalizumab and Fingolimod Analogous Second-Line Options for the Treatment of Relapsing-Remitting Multiple Sclerosis? A Clinical Practice Observational Study

Alberto Gajofatto, Maria Rachele Bianchi, Luciano Deotto et al. · European Neurology · 2014 · 39 citations

Medicine, Neurology, Pharmacotherapy +17

Benign course of tumour-like multiple sclerosis. Report of five cases and literature review

Marco Turatti, Alberto Gajofatto, Maria Rachele Bianchi et al. · Journal of the Neurological Sciences · 2012 · 16 citations

Medicine, Neurology, Pathology +8